Drug Trial Radar · NCT03539536
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: Nov 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
270
Actual
Start
Oct 10, 2018
Primary completion
Jul 2026
Study completion Aug 2026
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- May 29, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate efficacy in the selected population(s) (Stage 2). After the Stage 2 global enrollment is completed, an additional cohort at an alternate dose level will evaluate the safety and efficacy of telisotuzumab vedotin (Stage 3).
Conditions
- Non-small Cell Lung Cancer
Interventions
Telisotuzumab vedotinDrug
Intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate (ORR) (Stage 1 and Stage 2)Time frame: Up to approximately 3 years
- Number of Participants with Adverse Events (Alternate dose cohort)Time frame: Up to approximately 3 years
Locations
252 sites in 26 countries. Site status is shown where the registry gives one.
University of South Alabama /ID# 212939
Mobile, Alabama
Mayo Clinic Arizona /ID# 218550
Phoenix, Arizona
Highlands Oncology Group, PA /ID# 215600
Springdale, Arkansas
University of California, Los Angeles /ID# 203219
Los Angeles, California
LA Hematology-Oncology Med Group /ID# 203338
Orange, California
Sutter Medical Center Sacramen /ID# 203299
Sacramento, California
Icri /Id# 227835
Whittier, California
Univ of Colorado Cancer Center /ID# 203212
Aurora, Colorado
Duplicate_Rocky Mountain Cancer Centers - Lone Tree /ID# 215789
Lone Tree, Colorado
Advanced Cancer Treatment Center /ID# 239565
Brooksville, Florida
AdventHealth Celebration /ID# 215649
Celebration, Florida
Duplicate_Mayo Clinic /ID# 218488
Jacksonville, Florida
Duplicate_AdventHealth Cancer Institute - Orlando /ID# 239960
Orlando, Florida
Straub Clinic and Hospital /ID# 217905
Honolulu, Hawaii
Northwestern University Feinberg School of Medicine /ID# 203239
Chicago, Illinois
The University of Chicago Medical Center /ID# 203216
Chicago, Illinois
Duplicate_NorthShore University HealthSystem /ID# 215583
Evanston, Illinois
Ingalls Memorial Hosp /ID# 203228
Harvey, Illinois
Joliet Oncology-Hematology Associates, LTD /ID# 203238
Joliet, Illinois
Goshen Center for Cancer Care /ID# 215584
Goshen, Indiana
Univ Kansas Med Ctr /ID# 216804
Kansas City, Kansas
Cancer Center of Kansas /ID# 203235
Wichita, Kansas
Duplicate_Baptist Health /ID# 203283
Lexington, Kentucky
Duplicate_Norton Cancer Institute - St Matthews /ID# 203284
Louisville, Kentucky
Central Maine Medical Center /ID# 216583
Lewiston, Maine
Massachusetts General Hospital /ID# 203215
Boston, Massachusetts
Beth Israel Deaconess Medical Center /ID# 208124
Boston, Massachusetts
Dana-Farber Cancer Institute /ID# 203248
Boston, Massachusetts
Henry Ford Hospital /ID# 203220
Detroit, Michigan
Mayo Clinic - Rochester /ID# 215603
Rochester, Minnesota
Hattiesburg Clinic /ID# 227691
Hattiesburg, Mississippi
St. Lukes Cancer Institute /ID# 227697
Kansas City, Missouri
Washington University-School of Medicine /ID# 203217
St Louis, Missouri
Duplicate_Intermountain Health - St Vincent Regional Hospital - Cancer Centers o /ID# 203292
Billings, Montana
Duplicate_Dartmouth-Hitchcock Medical Center - 1 Medical Center Drive /ID# 203350
Lebanon, New Hampshire
Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 228868
East Brunswick, New Jersey
Atlantic Health System /ID# 203404
Morristown, New Jersey
Capital Health Medical Center /ID# 203403
Pennington, New Jersey
Overlook Medical Center /ID# 211160
Summit, New Jersey
University of New Mexico /ID# 208339
Albuquerque, New Mexico
Showing 40 of 252 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.